SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending following the submission of an expanded deep-sea mining permit application under NOAA's newly streamlined regulatory process, signaling a significant step towards commercial recovery. This, coupled with an upcoming Congressional hearing featuring TMC's CEO and recent White House support for expediting critical mineral permits, has fueled strong bullish sentiment among investors who see deep-sea resources as a national security priority, with many discussing significant upside potential and a potential short squeeze.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending due to significant strategic announcements, including a new post-quantum semiconductor joint venture in India and a potential acquisition of French quantum computing firm Quobly. The community is actively discussing the company's role in the critical and emerging quantum security sector, with many anticipating a short squeeze driven by high trading volume and a strong belief in the stock's long-term potential following recent positive financial updates and analyst upgrades.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals (SXTP) is seeing explosive trading volume after announcing a partnership to expand direct access to its ARAKODA malaria prevention drug for international travelers, coupled with news defining a potential $1.1 billion market for its babesiosis treatment. The low-float stock is drawing significant community attention, with traders discussing short-squeeze potential and chasing momentum amidst high volatility, though some express caution given the company's history of offerings.

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

Creative Media & Community Trust

Creative Media & Community Trust (CMCT) is generating significant buzz following the announcement of its lending division sale, which yielded substantial net cash proceeds. The community is actively discussing the potential for a parabolic short squeeze, driven by the stock's micro float and comparing its trajectory to other recent volatile movers, despite some mentions of its considerable outstanding debt.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences (GLSI) is generating significant buzz following FDA authorization for the use of its commercially manufactured GP2 drug product in the Phase III FLAMINGO-01 trial, marking a key de-risking milestone for its breast cancer immunotherapy. The community is sharply divided, with bulls pointing to the low float, high short interest, and ongoing insider buying as catalysts for a potential squeeze, while bears highlight a 'sell the news' pattern and anticipate further pullbacks.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid community discussions regarding a potential US government agreement concerning Greenland's mineral rights, which many believe directly benefits CRML's Tanbreez rare earth project. Investors are actively discussing the company's strategic importance in establishing a non-China heavy rare earth supply chain, with a recent business update call providing additional insights into project funding and development plans.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is actively trending as Chairman Ryan Cohen significantly increased his personal stake by purchasing an additional one million shares recently, reinforcing his commitment and challenging other CEOs to buy their company's stock. This substantial insider buying, coupled with another director's purchases, is igniting conversations among the community about potential for a renewed short squeeze and the company's long-term value, with many viewing it as a clear signal that the stock's bottom is established. Enthusiastic discussions highlight hopes for increased trading volume and a "round two" of significant price action, putting pressure on short positions amidst sustained retail interest.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is actively trending as the community anticipates a major hyperscaler tenant announcement for its expansive AI data center campus in West Texas, following a key acquisition and strategic partnership. Investors are intensely discussing the potential for a significant short squeeze and drawing comparisons to established data center infrastructure leaders, fueling strong bullish sentiment.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a recent $150 million registered direct offering, eliciting strong community debate. While some express concern over dilution, many investors see this capital raise as a vital strategic move to fund accelerated production and potential acquisitions for the burgeoning AI data center market. This move is viewed as institutional validation, positioning POET to capitalize on anticipated major orders with its innovative optical interposer technology.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending following a significant licensing deal with Pfizer for its Matrix-M adjuvant, validating the technology as a potential "gold standard" in vaccine development. This partnership, alongside existing deals, is fueling strong community speculation about a massive short squeeze given the substantial short interest. Investors are keenly discussing Matrix-M's broad applicability beyond current vaccines and its advantage as a non-aluminum adjuvant, while urging management to capitalize on this momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NovoCure Limited (NASDAQ:NVCR) Short Interest Update

NovoCure Limited (NASDAQ:NVCR - Get Free Report) saw a large increase in short interest in December. As of December 31st, there was short interest totaling 8,333,839 shares, an increase of 20.0% from...

Assessing NovoCure: Insights From 4 Financial Analysts

NovoCure (NASDAQ:NVCR) Receives Neutral Rating from Wedbush

Wedbush reaffirmed a "neutral" rating and issued a $18.00 price objective on shares of NovoCure in a report on Thursday...

HC Wainwright Has Bullish Estimate for NovoCure Q4 Earnings

NovoCure Limited (NASDAQ:NVCR - Free Report) - Research analysts at HC Wainwright raised their Q4 2025 earnings per share (EPS) estimates for NovoCure in a report issued on Tuesday, January 13th. HC...

NovoCure Limited (NASDAQ:NVCR) Receives Average Rating of "Hold" from Analysts

NovoCure Limited (NASDAQ:NVCR - Get Free Report) has earned an average recommendation of "Hold" from the seven brokerages that are currently covering the firm, MarketBeat.com reports. One equities...

Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update

Novocure (NASDAQ: NVCR) today reported preliminary unaudited financial and operational results for the quarter and full year ended December 31, 2025. Novocure is a global oncology company working to...

Moderna (MRNA) Soars 10.9%: Is Further Upside Left in the Stock?

Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Voya Investment Management LLC Sells 64,539,786 Shares of NovoCure Limited $NVCR

Voya Investment Management LLC lowered its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 100.0% in the third quarter, according to its most recent 13F filing with the...

Novocure (NVCR) Q2 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference

Novocure (NASDAQ: NVCR) announced today that management will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco on January 12-15, 2026. Frank Leonard...

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

NovoCure Ltd

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Current Price	$14.24
Prev Close	$13.56
Open	$13.66
Dividend Yield	0.00%
50-Day Moving Average	$12.74
Beta	1.40
Avg. Volume	1.68M
PE Ratio	-8.41

52-Week High	$27.32
52-Week Low	$10.70
Market Capitalization	$1.46B
EPS (Annual)	-$1.56
Price to Book	4.45
Revenue Per Employee	$406,733.87
Enterprise Value/EBITDA	N/A

NVCR
NovoCure Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NVCR News

NVCRNovoCure Ltd